CA2176460A1 - Procede de compression d'un melange sec de medicaments - Google Patents

Procede de compression d'un melange sec de medicaments

Info

Publication number
CA2176460A1
CA2176460A1 CA002176460A CA2176460A CA2176460A1 CA 2176460 A1 CA2176460 A1 CA 2176460A1 CA 002176460 A CA002176460 A CA 002176460A CA 2176460 A CA2176460 A CA 2176460A CA 2176460 A1 CA2176460 A1 CA 2176460A1
Authority
CA
Canada
Prior art keywords
medicaments
dry blend
agglomerated
excipients
disclosed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002176460A
Other languages
English (en)
Other versions
CA2176460C (fr
Inventor
Frank C. Greaves
James Swarbrick
Martin W. Beasley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Barr Pharmaceuticals Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from ZA939566A external-priority patent/ZA939566B/xx
Application filed by Individual filed Critical Individual
Publication of CA2176460A1 publication Critical patent/CA2176460A1/fr
Application granted granted Critical
Publication of CA2176460C publication Critical patent/CA2176460C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2095Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
CA002176460A 1993-12-21 1994-12-20 Procede de compression d'un melange sec de medicaments Expired - Lifetime CA2176460C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ZA93/9566 1993-12-21
ZA939566A ZA939566B (en) 1993-12-21 1993-12-21 Method for dry blend compression od medicaments.
PCT/US1994/014639 WO1995017169A1 (fr) 1993-12-21 1994-12-20 Procede de compression d'un melange sec de medicaments

Publications (2)

Publication Number Publication Date
CA2176460A1 true CA2176460A1 (fr) 1995-06-29
CA2176460C CA2176460C (fr) 2007-03-13

Family

ID=38007968

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002176460A Expired - Lifetime CA2176460C (fr) 1993-12-21 1994-12-20 Procede de compression d'un melange sec de medicaments

Country Status (1)

Country Link
CA (1) CA2176460C (fr)

Also Published As

Publication number Publication date
CA2176460C (fr) 2007-03-13

Similar Documents

Publication Publication Date Title
CA2111002A1 (fr) Formulations d'aerosol sans chlorofluorocarbure
CA2102630A1 (fr) Compositions pharmaceutiques de medicaments compactes
CA2258095A1 (fr) Compositions contenant de la tetrahydrolipstatine
CA2004598A1 (fr) Aerosols medicinaux
WO1995001782A3 (fr) Procede de fabrication de formes galeniques de medicaments lyophilises
GB9113219D0 (en) Peptide compound,processes for preparation thereof and pharmaceutical composition comprising the same
CA2105887A1 (fr) Dispositif bio-absorbable pour l'administration de composes actifs
CA2290017A1 (fr) Procede pour produire des formes galeniques solides pouvant etre administrees par voie orale, a liberation de principe actif controlee
CA2179207A1 (fr) Formulation d'hormone parathyroide
CA2265766A1 (fr) Pastilles se desintegrant rapidement
CA2128199A1 (fr) Compositions pharmaceutiques, solides, stables, renfermant du maleate d'enalapril
AU7702291A (en) Dietary fiber, its process and physiologically active composition containing the same as an active ingredient
CA2283408A1 (fr) Comprimes a avaler contenant du paracetamol
HU9302971D0 (en) Chewable antacid preparations
CA2268455A1 (fr) Methodes et appareil de traitement de la maladie de parkinson
EP0392487A3 (fr) Composition stabilisée contenant des anthracyclines
CA2088289A1 (fr) Composition a activite pharmaceutique extraite de tanacetum parthenium, procede pour son extraction et composition pharmaceutique la contenant
WO2000072820A3 (fr) Formulation anesthesique injectable
AU1439895A (en) Method for dry blend compression of medicaments
NZ234268A (en) Vasoactive intestinal peptide analogues, derivatives and pharmaceutical compositions
EP0369474A3 (fr) Composition pharmaceutique pour le traitement de l'oedème cérébral
CA2176460A1 (fr) Procede de compression d'un melange sec de medicaments
CA2502582A1 (fr) Formulation pharmaceutique d'olanzapine
AU6326094A (en) New medicament aerosol formulation based on fusafungine, a process for its preparation and pharmaceutical compositions containing it
AU4845196A (en) 2-sulfinylnicotinamide derivatives, intermediate thereof, process for producing 2-sulfinylnicotinamide derivatives, and medicinal composition containing the same as active ingredient

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20141222